Old Web
English
Sign In
Acemap
>
authorDetail
>
Allison Fortenberry
Allison Fortenberry
Biliary tract
Medicine
Single Arm Study
Internal medicine
open label
2
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase IIb, open-label, single-arm study of zanidatamab (ZW25) monotherapy in subjects with advanced or metastatic HER2-amplified biliary tract cancers.
2021
Journal of Clinical Oncology
Shubham Pant
Michel Ducreux
James J. Harding
Milind Javle
Do-Youn Oh
Harpreet Wasan
Allison Fortenberry
Neil C. Josephson
Anthony Mwatha
Kui Wang
Jia Fan
Show All
Source
Cite
Save
Citations (2)
Zanidatamab (ZW25) in HER2-positive biliary tract cancers (BTCs): Results from a phase I study.
2021
Journal of Clinical Oncology
Funda Meric-Bernstam
Diana L. Hanna
Anthony B. El-Khoueiry
Yoon-Koo Kang
Do-Youn Oh
Jorge Chaves
Sun Young Rha
Erika Paige Hamilton
Shubham Pant
Milind Javle
Kanwal Pratap Singh Raghav
Allison Fortenberry
Todd E. Gray
Joseph Woolery
Keun-Wook Lee
Show All
Source
Cite
Save
Citations (10)
1